Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial.

Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial.

Item
http://www.wikidata.org/entity/Q54582351
Environmental and phenotype-related risk factors for owner-reported allergic/atopic skin symptoms and for canine atopic dermatitis verified by veterinarian in a Finnish dog populationTreatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA).A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008-2011 update.In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell lines.Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells.Reliability and agreement in the use of four- and six-point ordinal scales for the assessment of erythema in digital images of canine skin.Masitinib-associated minimal change disease with acute tubular necrosis resulting in acute kidney injury in a dog.Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study.An Inflammation-Centric View of Neurological Disease: Beyond the Neuron.Masitinib monotherapy in canine epitheliotropic lymphoma.
P2860

Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial.

Item
http://www.wikidata.org/entity/Q54582351
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Masitinib decreases signs of c ...... cebo-controlled phase 3 trial.
@en
Masitinib decreases signs of c ...... cebo-controlled phase 3 trial.
@nl
type
label
Masitinib decreases signs of c ...... cebo-controlled phase 3 trial.
@en
Masitinib decreases signs of c ...... cebo-controlled phase 3 trial.
@nl
prefLabel
Masitinib decreases signs of c ...... cebo-controlled phase 3 trial.
@en
Masitinib decreases signs of c ...... cebo-controlled phase 3 trial.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Masitinib decreases signs of c ...... cebo-controlled phase 3 trial.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1365-3164.2011.00990.X
P433
P478
P50
P577
P698
P921